Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 3:53 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1897–1920 of 3,979 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Heart Failure With Normal Ejection Fraction, Heart Failure With Reduced Ejection Fraction, Heart Failure, Right Sided, Heart Failure With Mid Range Ejection Fraction, Cardiovascular Risk Factor
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Erectile Dysfunction
Interventions: avanafil and enalapril, avanafil and amlodipine; Drug
Lead sponsor: VIVUS LLC; Industry
Eligibility: 40 Years to 65 Years · Male only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Meibomian Gland Dysfunction
Interventions: Meibomian gland (MG) expression; Procedure
Lead sponsor: University of the Incarnate Word; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Obesity, Metabolic Dysfunction-associated Steatotic Liver Disease
Interventions: Survodutide, Placebo matching survodutide; Combination Product
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 15
States / cities: Peoria, Arizona • Los Angeles, California • Oxnard, California + 12 more

Conditions: Restrictive Chronic Lung Allograft Dysfunction, Lung Transplant Rejection
Interventions: Pirfenidone; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Left Ventricular Systolic Dysfunction, Congestive Heart Failure, Ischemic and Non-ischemic Cardiomyopathy, Sudden Cardiac Death Primary Prevention
Interventions: Not listed
Lead sponsor: Seattle Institute for Cardiac Research; Other
Eligibility: 18 Years to 90 Years
Enrollment: 1,855 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Bellevue, Washington

Conditions: Erectile Dysfunction
Interventions: Autologous Platelet Rich Plasma, Saline solution; Drug · Other
Lead sponsor: University of Miami; Other
Eligibility: 30 Years to 75 Years · Male only
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Erectile Dysfunction
Interventions: Naltrexone HCL/ Yohimbine HCL; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Male only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2004
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Epilepsy
Interventions: Memantine, Sugar Pill; Drug · Other
Lead sponsor: American Academy of Neurology; Other
Eligibility: 18 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 3
States / cities: Atlanta, Georgia • Boston, Massachusetts • Newton, Massachusetts

Conditions: Down Syndrome, Autonomic Dysfunction
Interventions: Cold Stress, Maximal Dynamic Exercise, Isometric Handgrip Exercise with Post-Exercise Muscle Ischemia, Head-up Tilt Table Test; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 50 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Peyronie Disease, Erectile Dysfunction
Interventions: Collagenase Clostridium Histolyticum, Storz Duolith LiSWT; Drug · Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Male only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cognitive Decline, Physical Activity, Psychological Wellbeing
Interventions: Virtual reality based mindful movement therapy; Behavioral
Lead sponsor: Drexel University; Other
Eligibility: 65 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Type 1 Diabetes
Interventions: Ramipril, Placebo; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 13 Years to 50 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 6
States / cities: Gainesville, Florida • Chicago, Illinois • Maywood, Illinois

Conditions: Sinus Node Dysfunction
Interventions: Reprogramming dual chamber pacemaker; Device
Lead sponsor: Arun Rao; Other
Eligibility: 60 Years to 95 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Kingsport, Tennessee

Conditions: Obesity, Endothelial Dysfunction, Vitamin D Deficiency
Interventions: Vitamin D3; Dietary Supplement
Lead sponsor: Mayo Clinic; Other
Eligibility: 12 Years to 18 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Kidney Diseases
Interventions: carboxypeptidase-G2; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: Not listed
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1992 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: RV - Right Ventricular Abnormality, LV Dysfunction, Pulmonary Hypertension, TOF
Interventions: Not listed
Lead sponsor: HBI Solutions Inc.; Industry
Eligibility: Up to 18 Years
Enrollment: 3,993 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2024
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Alzheimer Disease
Interventions: Donanemab, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 60 Years to 85 Years
Enrollment: 1,736 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 185
States / cities: Gilbert, Arizona • Phoenix, Arizona • Scottsdale, Arizona + 146 more

Conditions: Internal Carotid Artery Stenosis, Cognitive Impairment
Interventions: Revascularization, Intensive Medical Management (IMM) alone; Procedure · Other
Lead sponsor: Columbia University; Other
Eligibility: 35 Years to 86 Years
Enrollment: 392 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 56
States / cities: Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 45 more

Conditions: Delirium, Postoperative Cognitive Dysfunction
Interventions: Lumosity; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 60 Years to 90 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Mobility Limitation, Cognitive Impairment
Interventions: Neurorehabilitation of Standard Walking, Neurorehabilitation of Complex Walking, Sham Transcranial Direct Current Stimulation (Sham tDCS), Active Transcranial Direct Current Stimulation (Active tDCS); Behavioral · Device
Lead sponsor: University of Florida; Other
Eligibility: 65 Years to 110 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 3
States / cities: Gainesville, Florida

Conditions: Chronic Pain, Low Back Pain
Interventions: Computerized Chemosensory-Based Orbitofrontal Cortex Training for Pain, Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT); Combination Product
Lead sponsor: Evon Medics LLC; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Pasadena, Maryland

Conditions: Mild Cognitive Impairment
Interventions: Kundalini yoga and meditation, Memory Training; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 55 Years to 90 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Preterm, Parent-Child Relations, Parents, Development, Infant, Sensory Integration Dysfunction
Interventions: SENSE multisensory program, Monitored standard of care; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 1 Day to 7 Days
Enrollment: 215 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure

Drug Interaction Study of Avanafil and Enalapril or Amlodipine

The Impact of Dry Eye Syndrome on Metrics of Low Contrast Vision Before and After Meibomian Gland Expression

ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease

Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction

SCD-HeFT 10 Year Follow-up

Safety and Efficacy of Autologous Platelet-Rich Plasma for Erectile Dysfunction.

Effects of Yohimbine and Naltrexone on Sexual Function

Does Memantine Improve Verbal Memory Task Performance in Subjects With Partial Epilepsy and Memory Dysfunction?

Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome

Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease

Virtual Reality-based Mindful Movement Therapy for Seniors

PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)

A Comparison of Rate Response Performance in Pacemaker Patients With an Indication of Sinus Node Dysfunction

Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents

A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction

Pediatric Ventricle Function Assessment Study

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)

Prevention of Early Postoperative Decline

Combining tDCS and Neurorehabilitation to Treat Age-related Deficits of Mobility and Cognition: UPfront Walking Study

Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)

Memory Training Versus Yogic Meditation Training in Older Adults With Mild Cognitive Impairment

Sensory Optimization of the Hospital Environment